Correlation Between Krebs Biochemicals and DMCC SPECIALITY

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krebs Biochemicals and DMCC SPECIALITY at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krebs Biochemicals and DMCC SPECIALITY into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krebs Biochemicals and and DMCC SPECIALITY CHEMICALS, you can compare the effects of market volatilities on Krebs Biochemicals and DMCC SPECIALITY and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krebs Biochemicals with a short position of DMCC SPECIALITY. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krebs Biochemicals and DMCC SPECIALITY.

Diversification Opportunities for Krebs Biochemicals and DMCC SPECIALITY

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Krebs and DMCC is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Krebs Biochemicals and and DMCC SPECIALITY CHEMICALS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DMCC SPECIALITY CHEMICALS and Krebs Biochemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krebs Biochemicals and are associated (or correlated) with DMCC SPECIALITY. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DMCC SPECIALITY CHEMICALS has no effect on the direction of Krebs Biochemicals i.e., Krebs Biochemicals and DMCC SPECIALITY go up and down completely randomly.

Pair Corralation between Krebs Biochemicals and DMCC SPECIALITY

Assuming the 90 days trading horizon Krebs Biochemicals and is expected to under-perform the DMCC SPECIALITY. In addition to that, Krebs Biochemicals is 1.12 times more volatile than DMCC SPECIALITY CHEMICALS. It trades about -0.2 of its total potential returns per unit of risk. DMCC SPECIALITY CHEMICALS is currently generating about -0.18 per unit of volatility. If you would invest  34,285  in DMCC SPECIALITY CHEMICALS on November 28, 2024 and sell it today you would lose (4,275) from holding DMCC SPECIALITY CHEMICALS or give up 12.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Krebs Biochemicals and  vs.  DMCC SPECIALITY CHEMICALS

 Performance 
       Timeline  
Krebs Biochemicals and 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Krebs Biochemicals and has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
DMCC SPECIALITY CHEMICALS 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in DMCC SPECIALITY CHEMICALS are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, DMCC SPECIALITY is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Krebs Biochemicals and DMCC SPECIALITY Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krebs Biochemicals and DMCC SPECIALITY

The main advantage of trading using opposite Krebs Biochemicals and DMCC SPECIALITY positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krebs Biochemicals position performs unexpectedly, DMCC SPECIALITY can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DMCC SPECIALITY will offset losses from the drop in DMCC SPECIALITY's long position.
The idea behind Krebs Biochemicals and and DMCC SPECIALITY CHEMICALS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.